Biotech Experts Share Keys to Navigate Complex Regulations

I’ve found that the easiest way to handle regulatory requirements is to stop thinking of them as a checklist and start treating them as part of the study itself. Before a trial begins, I like to walk through the protocol carefully and compare it with the study procedures. That extra time upfront has helped me catch small gaps before they turned into bigger issues.

One thing experience has taught me is that regulations are always evolving, so I don’t assume that what worked on one study will apply to the next. I keep asking questions, confirm expectations with sponsors when needed, and never hesitate to verify something twice.

If I could offer one piece of advice, it would be to stay curious. The more you understand the reason behind a requirement, the easier it becomes to apply it confidently across different studies and trials.

I have learned that the path through biotech regulation starts with understanding that GOOD SCIENCE IS NOT EQUAL TO REGULATORY SUCCESS. A strong evidence base should be reflected in the interpretation of each biomarker, and all educational materials and public statements must adhere to applicable regulatory standards. Close coordination across scientific, clinical, and regulatory teams is essential to ensure that guidance is continually monitored and updated while avoiding redundancies, information overload, and misinformation. It also makes for a good consistency check, adding to credibility.

My suggestion is to adopt a regulatory mindset AS EARLY AS POSSIBLE, rather than treating it as a final check. One of the simplest but most powerful practices you can implement is to ask if all the available evidence supports each statement before it is disseminated. This minimizes revisions, improves consistency, and strengthens long-term trust among clinicians, patients, and regulators.

I speak from experience running a medical device regulatory technology company, not biotech directly, but the underlying challenge is the same across most regulated life sciences fields. It’s rarely one set of rules evolving. It’s dozens of regulatory systems, each with its own requirements, running in parallel, and companies often solve that market by market instead of building a repeatable way to handle it.

That’s the piece of advice that applies broadly, regardless of whether you’re in biotech, medical devices, or any other regulated industry: stop treating each new market as its own one-off project. Try to handle the next ten markets the same way you handled the first one instead of starting from scratch every time. The companies that never make that shift eventually find themselves buried in regulatory work faster than their team can grow to handle it.

Navigating regulations means treating compliance like the foundation of every partnership we build. At A-S Medication Solutions, we’ve thrived by staying locked in with FDA and DEA registration while earning VAWD accreditation from NABP. That combo lets us serve over 3,600 provider dispensing sites across all 50 states from our Libertyville headquarters, delivering point-of-care medication dispensing, prepackaged meds, mail-order programs, and wholesale distribution without missing a beat.

I don’t see regs as roadblocks. They’re the playbook that keeps patients safe and our model strong. When we roll out clinical pharmacy programs or home delivery, we research every state requirement first, then explain the tradeoffs clearly to clinics and government agencies so they know exactly how adherence improves when docs dispense right at the visit. We’ve prioritized automated tech to cut human error, and that focus builds trust faster than any sales pitch.

One piece of advice I’d give anyone in a regulated field: make transparency your default. Don’t hide the complexities. Walk stakeholders through what compliance costs in time and process, then show the upside in reliability and outcomes. We’ve done that with correctional facilities and public health groups, and it turns potential friction into long-term wins. Stay curious, double-check every guideline, and never cut corners on accreditation. That mindset has kept us solid since 1968, and it’ll carry you through whatever shifts come next.